Onodera, Kazunari
Shimojo, Daisuke
Ishihara, Yasuharu
Yano, Masato
Miya, Fuyuki
Banno, Haruhiko
Kuzumaki, Naoko
Ito, Takuji
Okada, Rina
de Araújo Herculano, Bruno
Ohyama, Manabu
Yoshida, Mari
Tsunoda, Tatsuhiko
Katsuno, Masahisa
Doyu, Manabu
Sobue, Gen
Okano, Hideyuki
Okada, Yohei https://orcid.org/0000-0001-5253-8556
Funding for this research was provided by:
Ministry of Health, Labour and Welfare
Japan Agency for Medical Research and Development (15ek0109025h0002, 16ek0109025h0003, 17ek0109243h0001, 18ek0109243h0002, 19ek0109243h0003, 19bm0804003h0003, 18dm0107105, 19dm0107105)
Ministry of Education, Culture, Sports, Science and Technology (JP15H01568, JP17H05707)
Japan Society for the Promotion of Science (JP17K19465)
Japan Society for the Promotion of Science (JP19H03576)
Article History
Received: 29 December 2019
Accepted: 29 January 2020
First Online: 19 February 2020
Ethics approval and consent to participate
: All the experimental procedures for human iPSC production and the use of human iPSCs were approved by the ethics committee of the Keio University School of Medicine (approval number 20080016) and the ethics committee of the Aichi Medical University School of Medicine (approval number 14–004). All the experimental procedures for human ESC cultures were approved by the ethics committee of the Keio University School of Medicine (approval number 2002-001).
: Not applicable.
: H.O. is a paid member of the Scientific Advisory Board of SanBio Co., Ltd. Y.O. is a scientific advisor of Kohjin Bio Co., Ltd. Other authors declare no conflict of interests.